Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress

Triulzi, Tiziana; Casalini, Patrizia; Sandri, Marco; Ratti, Manuela; Carcangiu, Maria L.; Colombo, Mario P.; Balsari, Andrea; Ménard, Sylvie; Orlandi, Rosaria; Tagliabue, Elda
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
We recently showed that differential expression of extracellular matrix (ECM) genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4) with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, β-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGFβ induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001). Cox models, estimated separately in grade I–II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3–7.0, p = 0.0098). Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT) genes in both grade I–II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III) phenotype. These findings support the key relevance of neoplastic and stroma interaction in breast cancer progression.


Related Articles

  • Ekspresija citokeratina 5/6 i citokeratina 17 u invazivnom karcinomu dojke. Ivković-Kapicl, Tatjana; Panjković, Milana; Nikolić, Ivan; Djilas-Ivanović, Dragana; Knežević-Ušaj, Slavica // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Dec2012, Vol. 69 Issue 12, p1031 

    Background/Aim. Cytokeratins (CK) 5/6 and 17, myoepithelial markers, are also expressed in a proportion of breast carcinomas. Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that shows common but heterogeneous morphological, genetical, and...

  • Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer. Fangyong Lei; Longjuan Zhang; Xinghua Li; Xi Lin; Shu Wu; Fengyan Li; Junling Liu // BMC Cancer;2014, Vol. 14 Issue 1, p50 

    Background Prostate tumor overexpressed 1 (PTOV1) was demonstrated to play an important role in cancer progression and was correlated with unfavorable clinical outcome. However, the clinical role of PTOV1 in cancer remains largely unknown. This study aimed to investigate the expression and...

  • Significance Analysis of Prognostic Signatures. Beck, Andrew H.; Knoblauch, Nicholas W.; Hefti, Marco M.; Kaplan, Jennifer; Schnitt, Stuart J.; Culhane, Aedin C.; Schroeder, Markus S.; Risch, Thomas; Quackenbush, John; Haibe-Kains, Benjamin // PLoS Computational Biology;Jan2013, Vol. 9 Issue 1, p1 

    A major goal in translational cancer research is to identify biological signatures driving cancer progression and metastasis. A common technique applied in genomics research is to cluster patients using gene expression data from a candidate prognostic gene set, and if the resulting clusters show...

  • EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Sato, Mototaka; Nakai, Yasutomo; Nakata, Wataru; Yoshida, Takahiro; Hatano, Koji; Kawashima, Atsunari; Fujita, Kazutoshi; Uemura, Motohide; Takayama, Hitoshi; Nonomura, Norio // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Purpose:Extracellular matrix metalloproteinase inducer (EMMPRIN) has been reported to play crucial roles, including in angiogenesis, in several carcinomas. However, the correlation between EMMPRIN levels and angiogenesis expression profile has not been reported, and the role of EMMPRIN in renal...

  • Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer. Rothé, Françoise; Ignatiadis, Michail; Chaboteaux, Carole; Haibe-Kains, Benjamin; Kheddoumi, Naïma; Majjaj, Samira; Badran, Bassam; Fayyad-Kazan, Hussein; Desmedt, Christine; Harris, Adrian L.; Piccart, Martine; Sotiriou, Christos // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Purpose: Aberrant microRNA (miRNA) expression is associated with cancer and has potential diagnostic and prognostic value in various malignancies. In this study, we investigated miRNA profiling as a complementary tool to improve our understanding of breast cancer (BC) biology and to assess...

  • Malignant Melanoma and Its Stromal Nonimmune Microecosystem. Piérard, Gérald E.; Piérard-Franchimont, Claudine; Delvenne, Philippe // Journal of Oncology;2012, p1 

    In recent years, rapid advances were reached in the understanding of a series of biologic signals influencing cutaneous malignant melanoma (CMM) cells. CMM is in close contact with a peculiar dermal extracellular matrix (ECM). Stromal cells store and release various structural ECM components....

  • Treatment of pT1N0 breast cancer: multigene predictors to assess risk of relapse. Fumagalli, D.; Sotiriou, C. // Annals of Oncology;Oct2010 Supplement 7, Vol. 21 Issue suppl_7, pvii103 

    Breast cancer is a complex disease and even at a favourable stage, such as the pT1N0 one, it is unlikely to be understood and cured by focusing only on single gene or protein alterations determined with suboptimal technologies, as the standard clinico-pathological predictors are. Improving...

  • 42P LOW EXPRESSION OF FGD3, A PUTATIVE GUANINE NUCLEOTIDE EXCHANGE FACTOR FOR CDC42, IS PROGNOSTIC OF POOR OUTCOME IN BREAST CANCER. Willis, S.; Young, B.; Williams, C.; Leyland-Jones, B. // Annals of Oncology;May2014 Supplement 1, Vol. 25 Issue suppl_1, pi14 

    No abstract available.

  • Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity. Wolf, Denise M.; Lenburg, Marc E.; Yau, Christina; Boudreau, Aaron; van ‘t Veer, Laura J. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Co-expression modules are groups of genes with highly correlated expression patterns. In cancer, differences in module activity potentially represent the heterogeneity of phenotypes important in carcinogenesis, progression, or treatment response. To find gene expression modules active in breast...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics